×
Personalis Price to Free Cash Flow Ratio 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Personalis price to free cash flow ratio from 2018 to 2024. Price to free cash flow ratio can be defined as
View More
Personalis Price to Free Cash Flow Ratio 2018-2024 | PSNL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Personalis price to free cash flow ratio from 2018 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$12.6B
BridgeBio Pharma (BBIO)
$5.1B
Bausch Health Cos (BHC)
$3.4B
Amphastar Pharmaceuticals (AMPH)
$2.4B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$307M
Assembly Biosciences (ASMB)
$106M
Grace Therapeutics (GRCE)
$30M
Sol-Gel Technologies (SLGL)
$16M
Evoke Pharma (EVOK)
$5M
Teligent (TLGT)
$0M